EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has named Robert McMahon as its next Chief Financial Officer, effective August 4. McMahon will succeed current CFO Bernard Birkett, who will remain with the company through year-end in an advisory capacity to support a smooth leadership transition.
McMahon brings more than three decades of financial and executive leadership in the healthcare sector. Since 2018, he has served as CFO of Agilent Technologies, where he oversaw a broad range of functions, including finance, audit, treasury, tax, investor relations, IT, and procurement. His previous roles include CFO at Hologic, Inc., and over 20 years with Johnson & Johnson in various senior financial positions.
West’s leadership framed the appointment as a strategic move to support the company’s long-term growth trajectory. The company, a leading global manufacturer of injectable drug packaging and delivery systems, continues to expand its role in pharmaceutical and biotech markets.
In addition to his executive experience, McMahon has served on the board of OraSure Technologies, Inc. since 2023. His appointment underscores West’s focus on experienced financial leadership as it navigates evolving industry dynamics and investor expectations.
Birkett, who has served as CFO since 2018, will transition into a Senior Advisor role reporting to CEO Eric M. Green until his retirement later this year.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.